drugset / Trial / NCT06436976
The Effect of Probiotics ATG-F4 in Cancer Patients
NaSingle-groupOpen-labelSupportive care
Summary
Patients with advanced colorectal cancer or pancreatic cancer who are receiving oxaliplatin-based chemotherapy will be included. The research participants in this study will consume probiotics along with safety and anti-cancer agent side effect-related questionnaires, blood, and fecal sample collection for up to 12 weeks from the date of registration. The total duration of participation for research subjects is 12 weeks.
Timeline
- Start
- 2024-03-01
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LT-002 | Unknown | 4e+10 unknown | — |